Yeast Derived Recombinant Epidermal Growth Factor 6.3KD Human EGF For Serum - Free Medium

Yeast Derived Recombinant Epidermal Growth Factor 6.3KD For Serum - Free Medium​

Description

In cell culture, the advantages of serum-free medium are:

1. To avoid the quality of serum batches between the changes and improve the cell culture and experimental results of repeatability.
2. To avoid the toxic effects of serum on serum and serum-borne contamination.
3. To avoid the impact of serum components on the experimental study.
4. In vitro culture of cells conducive to differentiation.
5. The expression level of the product can be increased and the cell product can be easily purified.
Healthgen Biotech rhEGF is derived from rice endosperm, which is animal component free, can avoid the contaminants. rEGF is a very active and indispensable ingredient in the serum-free medium.

Quick detail

1. CAS No.: 62253-63-8
2. Other Names: rhEGF, Recombinant epidermal growth factor, recombinant EGF, rEGF, EGF
3. EINECS No.: 263-468-7
4. Place of Origin: Wuhan, China (Mainland)
5. Brand Name: Oryzogen
6. Model Number: HYC020M01
7. Purity: Greater than 98 % as determined by SDS-PAGE
8. Source: Yeast

Physiological and Biochemical Properties of our rhEGF and rEGF(E.coli)

Advantages

1. The lyophilized powder rhEGF can keep the stability and bioactivity. The lyophilized powder effectively prevents the changes of physical, chemical properties and biological characteristics of rhEGF. It has small damage to biological structure and characteristics of the dormant state and can make them quickly enter the sleep state. So the rhEGF freeze-dried powder can be stored at -20 ℃ for more than 24 months. The appearance of our rhEGF powder is white color, which is the same as the EGF derived from E.coli. 

2. Wuhan Healthgen Biotechnology Corp. is a private company founded in 2006. We specialize in molecular pharmaceutical technology research and high-tech innovation-oriented product development, which is developing, manufacturing and marketing a series of recombinant proteins and growth factors by rice endosperm platform. We have 400 square meters of research center, in which 30% of the research personnels have doctoral degree and major in different directions of the research and development. Healthgen Biotech has strong capability in developing a series of biological products.

Supplemental Description

Healthgen Biotech has strong technical force and advanced and complete protein expression and purification technology development and large-scale production facilities. Self-developed rice endosperm cell expression platform (Oryz^HiExp), which is domestic initiative and the international leader, has such advantages: high expression level, safety, scale-up easily, simple production process and environmental protection etc. After 10 years of unremitting efforts, Healthgen Biotech has established recombinant protein expression and purification technology platform to customize recombinant protein or peptide expression and purification process service for pharmaceuticals, health products, scientific research and industrial reagents. Using the Oryz^HiExp platform, Healthgen Biotech has achievements in developing and commercializing a series of medium ingredients, including recombinant human serum albumin(OsrHSA), recombinant α-1 antitrypsin(OsrhAAT), recombinant human lactoferrin(OsrhLF), recombinant human basic fibroblast growth factor (OsrhbFGF), recombinant human insulin-like growth factor-1 LR3(rhIGF-1 LR3) , recombinant human epidermal growth factor(rhEGF) and recombinant human fibronectin(OsrhFN), which can provide a full set of solutions for animal component free .